In Vivo Testing for Gold Nanoparticle Toxicity
A technique for measuring the toxicity of nanomaterials using a murine model is described. Blood samples are collected via submandibular bleeding while urine samples are collected on cellophane sheets. Both biosamples are then analyzed by inductively coupled plasma optical emission spectroscopy (ICP-OES) for nanotoxicity. Blood samples are further tested for immunological response using a standard Coulter counter. The major organs of interest for filtration are also digested and analyzed via ICP-OES, producing useful information regarding target specificity of the nanomaterial of interest. Collection of the biosamples and analysis afterward is detailed, and the operation of the technique is described and illustrated by analysis of the nanotoxicity of an injection of a modified tiopronin monolayer-protected cluster.
Key wordsNanotoxicity Murine model Biodistribution Tissue analysis Organ digestion
- 5.Everts M, Saini V, Leddon JL, Kok RJ, Stoff-Khalili M, Preuss MA, Millican CL, Perkins G, Brown JM, Bagaria H, Nikles DE, Johnson DT, Zharov VP, Curiel DT (2006) Covalently linked Au nanoparticles to a viral vector: potential for combined photothermal and gene cancer therapy. Nano Lett 6:587–591CrossRefGoogle Scholar
- 21.Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318Google Scholar
- 24.Armstrong JK, Leger R, Wenby RB, Meiselman HJ, Garratty G, Fisher TC (2003) Occurrence of an antibody to poly(ethylene glycol) in normal donors. Blood 102:556AGoogle Scholar
- 25.Leger RM, Arndt P, Garratty G, Armstrong JK, Meiselman HJ, Fisher TC (2001) Normal donor sera can contain antibodies to polyethylene glycol (PEG). Transfusion 41:29SGoogle Scholar